Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
---|
10/27/2005 | WO2005099687A2 Analogs of salinosporamide a |
10/27/2005 | WO2005061433A3 Aminoalcohol derivatives |
10/27/2005 | US20050239896 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke, depression, glaucoma |
10/27/2005 | US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain |
10/27/2005 | CA2562170A1 5-aminolevulinic acid salt, process for producing the same and use thereof |
10/27/2005 | CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis |
10/26/2005 | EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
10/26/2005 | EP1588998A1 A process for the preparation of 2-chloro-3-(phenylmethoxy)propionic acid potassium salt |
10/26/2005 | EP1587783A2 Cycloalkyl containing anilide ligands for the thyroid receptor |
10/26/2005 | CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs |
10/26/2005 | CN1687013A Coated lycine or its salt, and coating technique |
10/26/2005 | CN1224609C Process for preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties |
10/25/2005 | US6958411 Antitumor agent; viricide |
10/25/2005 | US6958352 Compounds for inhibiting insulin secretion and methods related thereto |
10/25/2005 | CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
10/20/2005 | WO2005097773A1 1,1’-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors |
10/20/2005 | WO2005097734A1 Method of purifying amino acid |
10/20/2005 | WO2005097733A1 Process for the preparation of enantiomerically enriched beta amino acid derivatives |
10/20/2005 | WO2005097727A1 Processes for the preparation of iodinated amino-aryl compounds |
10/20/2005 | WO2005097713A1 Fluoridation method |
10/20/2005 | WO2005097102A2 Method to treat chronic heart failure and/or elevated cholesterol levels |
10/20/2005 | WO2005097100A2 Antibacterial agents |
10/20/2005 | WO2005097093A1 Sleep inducing compounds and methods relating thereto |
10/20/2005 | US20050234265 2-aminomethyl-5-tert-butyl-3-phenylphenol; antimalaria; used against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia |
10/20/2005 | US20050234131 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
10/20/2005 | US20050234129 Salts of nateglinide |
10/20/2005 | US20050234020 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia |
10/20/2005 | CA2561973A1 Process for the preparation of enantiomerically enriched beta amino acid derivatives |
10/20/2005 | CA2560648A1 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors |
10/20/2005 | CA2560313A1 Processes for the preparation of iodinated amino-aryl compounds |
10/19/2005 | EP1586555A2 Storage stable iminodisuccinates solutions |
10/19/2005 | EP1586548A1 Process for the preparation of 3,3-dimethylbutanal |
10/19/2005 | EP1585745A1 Fc receptor modulating compounds and compositions |
10/19/2005 | EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
10/19/2005 | EP1585479A2 Synthesis of 4amino-2-butenoyl chlorides and their use in the preparation of 3-cyano quinolines |
10/19/2005 | EP1194414B1 Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate |
10/19/2005 | CN1684678A Thiomolybdate analogues and uses thereof |
10/19/2005 | CN1683322A Process for preparing gabapentin |
10/19/2005 | CN1683321A Degradable chelate surfactant and producing method |
10/18/2005 | US6955915 Solid phase synthesis; photolithography |
10/18/2005 | CA2211934C 2-phenyl-2-(2'-piperidinylidene)acetate derivative, process for manufacturing the same, and process for manufacturing optically active 2-phenyl-2-(2'-piperidinyl)acetate derivative by asymmetrically hydrogenating the same |
10/18/2005 | CA2156288C Glycerol derivative, device and pharmaceutical composition |
10/18/2005 | CA2144228C Saturated fluoroalkylamines and their derivatives, and mixtures thereof |
10/13/2005 | WO2005095360A1 Neurologically-active compounds |
10/13/2005 | WO2005095325A1 PROCESS FOR THE PREPARATION OF β-AMINOCARBOXYLIC ACIDS |
10/13/2005 | WO2005058798A8 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same |
10/13/2005 | US20050228190 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin |
10/13/2005 | US20050228181 Serotonin receptor antagonists; nervous system disorders, R)-4-(2,3-dihydro-1,4-benzodioxin-5-yl)- beta -methyl-1-piperazineethanol |
10/13/2005 | US20050226776 Use of microfabricated devices |
10/13/2005 | CA2563038A1 Neurologically-active compounds |
10/12/2005 | EP1583738A1 Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia |
10/12/2005 | CN1681936A Process for producing optically active erythro 3-cyclohexylserines |
10/12/2005 | CN1681776A Amino alcohol derivative, addition salt thereof, and immunosuppressant |
10/12/2005 | CN1680313A Farnesyl transferase inhibitors |
10/12/2005 | CN1680310A Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation |
10/12/2005 | CN1680298A Material and intermediate for trifluoromethyl-substituted spirocyclic ketoenols |
10/12/2005 | CN1680293A Processes for the production of alpha-difluoromethyl ornithine (dfmo) |
10/12/2005 | CN1680281A Process for preparing amino acid esters and their acid addition salts |
10/11/2005 | US6953865 reacting (R)- or (S)- nitryloxycarnitine with sodium azide; hydrogenation to the intermediate azidocarnitine of same configuration; no isolation |
10/11/2005 | US6953792 Cyclohexyl derivatives and their use as therapeutic agents |
10/11/2005 | CA2226668C Aromatic esters of polyalkylphenoxyalkanols and fuel compositions containing the same |
10/06/2005 | WO2005092937A1 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent |
10/06/2005 | WO2005092838A1 Acid addition salts of 5-aminolevulinic acid or its derivatives |
10/06/2005 | WO2005092837A2 Process for the preparation of gabapentin |
10/06/2005 | WO2005092011A2 Mitotic kinesin inhibitors |
10/06/2005 | US20050222524 Apparatus and method for applying variable localized pressure to the human body |
10/06/2005 | US20050222378 Methods of synthesis of polysuccinimide, copolymers of polysuccinimide and derivatives thereof |
10/06/2005 | US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative |
10/06/2005 | US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
10/06/2005 | US20050222213 Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents |
10/06/2005 | US20050222089 taxane is prepared by esterifying an appropriate baccatin carrying a C-13 hydroxyl functional group with an acid derivative and is obtained by controlled saponification |
10/06/2005 | US20050217816 Storage-stable iminodisuccinate solutions |
10/06/2005 | DE102004012873A1 Lagerstabile Iminodisuccinatlösungen Storage stable Iminodisuccinatlösungen |
10/06/2005 | CA2560388A1 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent |
10/06/2005 | CA2560213A1 Mitotic kinesin inhibitors |
10/05/2005 | EP1582514A1 Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production |
10/05/2005 | EP1581487A2 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
10/05/2005 | EP1581475A1 Synthesis of (r) and (s)-aminocarnitine and derivatives thereof from d-and l-aspartic acid |
10/05/2005 | EP1581467A2 Ligands for metals and improved metal-catalyzed processes based thereon |
10/05/2005 | EP1581205A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
10/05/2005 | EP0621779B1 Indomethacin lysinate for therapeutic use in ophthalmology |
10/05/2005 | CN1678791A Method for delivering biologically active substances |
10/05/2005 | CN1678395A Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions |
10/05/2005 | CN1221557C Process for prepairng N-phosphonomethyl iminodiacetic acid |
10/05/2005 | CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
10/05/2005 | CN1221525C Process for the synthesis of 1-(aminomethyl) cyclohexyl-acetic acid |
10/05/2005 | CN1221524C Diphenyl ether compounds useful in therapy |
10/04/2005 | US6951943 Integrin inhibitors |
10/04/2005 | US6951889 7-acetamidinyl derivatives |
10/04/2005 | US6951844 substituted 5-phenyl-2-naphthols; metabolic disorders |
09/29/2005 | WO2005090283A1 Methods of amination |
09/29/2005 | WO2005089734A2 Creatine salt enhanced nutritional and therapeutic efficacy and compositions containing same |
09/29/2005 | WO2005089354A2 Apparatus and method for applying variable localized pressure to the human body |
09/29/2005 | WO2005041925A3 Compositions and dosage forms for enhanced absorption |
09/29/2005 | US20050215816 Cyclic ketones, their preparation and their use in the synthesis of amino acids |
09/29/2005 | US20050215812 Processes for the preparation of iodinated amino-aryl compounds |
09/29/2005 | US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate |
09/29/2005 | US20050214828 Using ultrviolet laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics |
09/28/2005 | EP1580186A1 Secondary p-phenylendiamines containing a carboxylic acid group, dye composition containing them, processes and uses |
09/28/2005 | EP1578898A2 Nad synthetase inhibitors and uses thereof |